Standard Biotools (LAB) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.48% |
| Dec 31, 2025 | 25.00% |
| Sep 30, 2025 | 21.33% |
| Jun 30, 2025 | 26.18% |
| Mar 31, 2025 | 26.29% |
| Dec 31, 2024 | 25.16% |
| Sep 30, 2024 | 24.65% |
| Jun 30, 2024 | 24.20% |
| Mar 31, 2024 | 25.94% |
| Dec 31, 2023 | -32.30% |
| Sep 30, 2023 | -51.10% |
| Jun 30, 2023 | -39.35% |
| Mar 31, 2023 | -31.95% |
| Dec 31, 2022 | -35.89% |
| Sep 30, 2022 | -29.24% |
| Jun 30, 2022 | -125.10% |
| Mar 31, 2022 | 100.62% |
| Dec 31, 2021 | 12.19% |
| Sep 30, 2021 | 7.88% |
| Jun 30, 2021 | 164.54% |
| Mar 31, 2021 | 169.02% |
| Dec 31, 2020 | 3.89% |
| Sep 30, 2020 | 4.13% |
| Jun 30, 2020 | -0.07% |
| Mar 31, 2020 | -0.13% |
| Dec 31, 2019 | 0.42% |
| Sep 30, 2019 | 1.02% |
| Jun 30, 2019 | 1.30% |
| Mar 31, 2019 | 1.71% |
| Dec 31, 2018 | -5.64% |
| Sep 30, 2018 | -25.40% |
| Jun 30, 2018 | -18.75% |
| Mar 31, 2018 | -13.47% |
| Dec 31, 2017 | -21.02% |
| Sep 30, 2017 | -17.57% |
| Jun 30, 2017 | -15.02% |
| Mar 31, 2017 | -15.03% |
| Dec 31, 2016 | -1.32% |
| Sep 30, 2016 | 2.82% |
| Jun 30, 2016 | -15.03% |
| Dec 31, 2015 | 21.13% |